Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
3
×
boston top stories
life sciences
national blog main
national top stories
boulder/denver blog main
clinical trials
detroit blog main
europe blog main
europe top stories
fda
indiana blog main
new york blog main
raleigh-durham blog main
san diego blog main
san francisco blog main
seattle blog main
texas blog main
wisconsin blog main
38 studios
abbvie
accelerator
aidan petrie
alkermes
allergan
arena pharmaceuticals
bankruptcy
bio
boston
boston red sox
boulder/denver top stories
buprenorphine
cancer
cardiovascular disease
cariprazine
city
civic
cluster
colorectal cancer
What
weight
3
×
drug
fda
medicine
alkermes
antipsychotic
benefits
better
boston’s
cancer
capital
caveats
city
commonly
designed
effect
eisai
favor
fights
flags
founder
gain
higher
incidence
island
jobs
life
little
lorcaserin
loss
market
marketing
offer
panel
patients
post
prescribed
providence
psyche
pulls
Language
unset
Current search:
weight
×
" boston blog main "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
5 years ago
In Boston’s Shadow, Rhode Island Fights for Life Science Jobs, Respect